Urgent.News

What's breaking now, across hundreds of outlets.

World

Health Canada approves new Eli Lilly GLP-1 pill for weight loss

Eli Lilly's Foundayo is also approved to help treat Type 2 diabetes.

Health Canada approves new Eli Lilly GLP-1 pill for weight loss

Health Canada recently approved Eli Lilly's GLP-1 medication, Foundayo, for weight loss. Foundayo is a daily pill, unlike the weekly injections typically required for this type of treatment. The drug is approved for adults with obesity and those who are overweight but have at least one related medical condition, such as high blood pressure or sleep apnea.

In addition to aiding weight loss, Foundayo can also help manage Type 2 diabetes. Eli Lilly also produces injectable medications Mounjaro and Zepbound, containing tirzepatide, a compound that targets two receptors related to insulin production and hunger: GLP-1 and GIP. The GLP-1 class of drugs has transformed weight-loss treatments, and some patients may prefer the convenience of taking a pill over injections.

Novo Nordisk manufactures Ozempic and Wegovy, injectables with the active ingredient semaglutide, which acts on GLP-1 receptors. Other companies also produce generic semaglutide in Canada. Health Canada approved Foundayo, which contains orforglipron, a non-peptide GLP-1 receptor agonist. Orforglipron's smaller molecular size allows it to be taken orally and absorbed without being broken down by the digestive system.

Dr. Ehud Ur, an endocrinologist, believes orforglipron may be as effective as semaglutide and tirzepatide for weight loss. Common side effects of GLP-1 medications include gastrointestinal issues like nausea or vomiting. Dr. Ur is waiting for clinical trial results to determine if orforglipron has cardiovascular benefits like semaglutide and tirzepatide.

Foundayo was approved by Health Canada on November 13, and Eli Lilly expects it to be available in pharmacies by January. Novo Nordisk is also developing a pill version of Wegovy, which contains semaglutide, but it has yet to receive approval in Canada. Both Foundayo and Wegovy are already approved and available in the U.S.

Rewritten by urgent.news; may contain errors — check the original.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at globalnews.ca →

Report a problem with this story

More in World

More from Wednesday 18 November →